chr2-230873465-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_030926.6(ITM2C):c.169G>A(p.Gly57Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000609 in 1,609,392 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_030926.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152212Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000101 AC: 25AN: 247160Hom.: 0 AF XY: 0.000142 AC XY: 19AN XY: 133794
GnomAD4 exome AF: 0.0000652 AC: 95AN: 1457062Hom.: 1 Cov.: 36 AF XY: 0.0000924 AC XY: 67AN XY: 724724
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152330Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.169G>A (p.G57S) alteration is located in exon 2 (coding exon 2) of the ITM2C gene. This alteration results from a G to A substitution at nucleotide position 169, causing the glycine (G) at amino acid position 57 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at